Seed VC · Solna, Sweden
Karolinska Development is a Sweden-based investment company specializing in the commercialization of innovative medical research, primarily originating from the Karolinska Institutet and other Nordic universities. Established in 2003, the company focuses on identifying, financing, and developing early-stage life science companies with the potential for significant medical and commercial impact. Karolinska Development has played a key role in advancing several biotech and pharmaceutical ventures, contributing to the growth of the Nordic life sciences sector. The company is publicly listed on Nasdaq Stockholm and is recognized for its strong ties to academic research and its commitment to fostering breakthrough healthcare solutions.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Karolinska Development writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Karolinska Development alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Karolinska Development is one of them — and we'll tell you exactly where they sit in your top 100.